• Mon. Jan 18th, 2021

Dimancherouge

Technology

dose

  • Home
  • Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study — ScienceDaily

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study — ScienceDaily

Virologists from the KU Leuven Rega Institute in Belgium have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose…